Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

NCT00727207 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped Lack of participations (8 of 25)

Conditions

Lymphoma

Interventions

DRUG: everolimus

Sponsor

Technical University of Munich